Seawolf Therapeutics
Seawolf Therapeutics develops DNA-based medicines using a redosable lipid nanoparticle delivery platform.
UndisclosedSeries A financing disclosure
ParticipantActivity from announced rounds
Seawolf Therapeutics develops DNA-based medicines using a redosable lipid nanoparticle delivery platform.
Bionyra Pharma develops biologic therapies for severe immunological and inflammatory diseases.
Provides supply chain security for IT infrastructure
Crossbow Therapeutics develops antibody therapies for cancer.
Detects, geolocates, and characterizes RF signals using a commercial satellite constellation
Develops inhaled therapies for severe respiratory diseases
Develops medicines targeting historically undruggable protein targets in cancer